News

April 1, 2020

NORML Issues Cannabis Policy Guidance For Lawmakers and Prosecutors For Protecting Public Health During COVID-19 Crisis

Today, NORML and it’s national network of advocacy chapters released a memo to state lawmakers, regulators, prosecutors, and other interested parties providing guidance for how they can take emergency actions to better promote the health and welfare of cannabis consumers and the general public during the COVID pandemic.
March 30, 2020

Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent

“Claims about the benefits of using CBD on viral infections were largely supported by CBD online retailers and most often appear to be a biased interpretation of the scientific literature or a dishonest manipulation of the information for commercial purposes.”
March 27, 2020

Poll: Majority of Americans Favor Designating Cannabis Dispensaries as “Essential Services”

A majority of Americans agree with states’ decisions to classify licensed medical cannabis facilities as “essential services” to the community – a designation that permits them to maintain retail operations during regional ‘stay-at-home’ orders.
March 26, 2020

NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”

“These new rules are unduly onerous, expensive, and impractical. Even if they are ultimately implemented, it is unlikely that they would greatly facilitate clinical cannabis research in the United States.”